The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines is a research paper published in Frontiers in Endocrinology (2020). On theSindex it has a DataRank of 0. It has been cited 112 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01-DK55758, RC2-DK118620, P01-DK088761, R01-DK099110
NIDDK NIH HHS
Grant: R01 DK055758
NIDDK NIH HHS
Grant: P01 DK088761
NIDDK NIH HHS
Grant: RC2 DK118620
NIA NIH HHS
Grant: P01 AG051459
NIDDK NIH HHS
Grant: R01 DK099110
National Institutes of Health
Grant: 5RC2DK118620-05
Generation of Novel Genetic Tools to Study Cellular Heterogeneity in Adipose Tissues
National Institutes of Health
Grant: 1R01DK055758-01A1
ACRP, A PROTEIN SECRETED FROM ADIPOSE TISSUE
National Institutes of Health
Grant: 5P01DK088761-04
Novel Mechanisms Regulating the Adipocyte-Brain Hepatocyte Axis
National Institutes of Health
Grant: 5R01DK099110-08
White Adipose Tissue Physiology, Mitochondrial Function and Adiponectin
National Institutes of Health
Grant: 5P01AG051459-04
Impact of FGF21 on healthspan and lifespan
National Institute on Aging
FWCI
3.49
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Biomarkers of mammographic density in premenopausal women
Additional file 1 of Biomarkers of mammographic density in premenopausal women
Additional file 1 of Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
Additional file 1 of Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
Additional file 2 of Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
Additional file 2 of Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
Additional file 1 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 1 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 2 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 2 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 3 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 3 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 6 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 6 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 4 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 5 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 5 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 4 of Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Additional file 1 of Circulating ceramide levels and ratios in Emirati youth under 18 years: associations with cardiometabolic risk factors
Additional file 1 of Circulating ceramide levels and ratios in Emirati youth under 18 years: associations with cardiometabolic risk factors